Drug Trial Radar · NCT06910839
Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity
Last checked: Nov 19, 2026Latest source record: Aug 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
21
Actual
Start
Mar 13, 2025
Primary completion
May 1, 2025
Study completion May 20, 2025
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Apr 4, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to see how two study medicines, PF-07976016 and danuglipron, taken together affect the level of each other in the blood of participants who have overweight or obesity. The total number of weeks of the study is up to approximately 22 weeks (5.5 months).
Conditions
- Overweight
- Obesity
Interventions
PF-07976016Drug
PF-07976016 oral tablets
PF-06882961Drug
PF-06882961 oral tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Steady state area under the concentration-time profile for PF-07976016Time frame: From 0 Hours to 24 Hours following steady-state dose
- Steady state maximum observed concentration (Cmax) for PF-07976016Time frame: From 0 Hours to 24 Hours following steady-state dose
- Steady state area under the concentration-time profile danuglipronTime frame: From 0 Hours to 24 Hours following steady-state dose
- Steady state maximum observed concentration (Cmax) for danuglipronTime frame: From 0 Hours to 24 Hours following steady-state dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Anaheim Clinical Trials, LLC
Anaheim, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.